Cargando…
High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous disease of the hematopoietic system, for which identification of novel molecular markers is potentially important for clinical prognosis and is an urgent need for treatment optimization. METHODS: We selected C-type lectin domain family 11,...
Autores principales: | Yin, Chengliang, Zhang, Junyan, Guan, Wei, Dou, Liping, Liu, Yuchen, Shen, Ming, Jia, Xiaodong, Xu, Lu, Wu, Rilige, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966831/ https://www.ncbi.nlm.nih.gov/pubmed/33747924 http://dx.doi.org/10.3389/fonc.2021.608932 |
Ejemplares similares
-
CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma
por: Yu, Qianle, et al.
Publicado: (2020) -
Intensified-Dose Chemotherapy in Combination With Gemtuzumab-Ozogamicin for the Treatment of Favorable-Risk Acute Myeloid Leukemia (AML)
por: Vegunta, Rathnamitreyee, et al.
Publicado: (2022) -
Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2019) -
Interpretable clinical visualization model for prediction of prognosis in osteosarcoma: a large cohort data study
por: Li, Wenle, et al.
Publicado: (2022) -
Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients
por: Zheng, Yang, et al.
Publicado: (2022)